Fundraising FoxadMare BioInnovations — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Epitopeaepitopea.cominOct 2024
Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.
AI & Machine LearningBiotechHealthtechMontreal, CA
Claude PerreaultPierre Thibault
Co-investorsAdvent Life SciencesCambridge Innovation CapitalCTI Life Sciences Fund L.P.Fonds de solidarité FTQ
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.